Regeneron Pharmaceuticals Inc. buy Sanford C. Bernstein
Summary
This prediction ended on 08.01.26 with a price of €689.60. With a performance of -2.21%, the BUY prediction for Regeneron Pharmaceuticals Inc. by Sanford_C__Bernstein closed slightly in the red. Sanford_C__Bernstein has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. A total of €3.48 was paid as dividends for this prediction. Sanford_C__Bernstein has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -0.125% | -0.125% | 28.843% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Sanford_C__Bernstein for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.
Current prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
27.08.25
27.08.26
17.04.26
Stopped prediction by Sanford_C__Bernstein for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
08.04.26
08.04.27
17.04.26
Regeneron Pharmaceuticals Inc.
12.03.24
12.03.25
13.03.25

